OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 09/10/2026 at 18:00, 15 days 11 hours ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding a decrease in shareholding percentage. The company is focused on technology-enabled clinical research and software platform

Clinical Research Transparency Notification Shareholding Oxurion NV Technology-enabled
PRESS RELEASE

published on 09/10/2026 at 18:00, 15 days 11 hours ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt een transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen. Oxurion is actief in klinisch onderzoek en software voor de life sciences sector

Transparantiekennisgeving Software Oxurion NV Atlas Special Opportunities II LLC Klinisch Onderzoek
BRIEF

published on 07/21/2026 at 08:05, 2 months 4 days ago

Oxurion renforce ses capacités de recherche clinique grâce à un partenariat stratégique

Partenariat Recherche Clinique Oxurion Biométrie Grâce À La Technologie
BRIEF

published on 07/21/2026 at 08:05, 2 months 4 days ago

Oxurion renforce sa plateforme de recherche clinique avec un nouveau partenariat biométrique

Oxurion Axiodis CRO Partenariat Biométrique Plateforme Clinique KYomed INNOV
BRIEF

published on 07/21/2026 at 08:05, 2 months 4 days ago

Oxurion strengthens its clinical research platform with a new biometric partnership

Oxurion Axiodis CRO KYomed INNOV Biometric Partnership Clinical Platform
BRIEF

published on 07/21/2026 at 08:05, 2 months 4 days ago

Oxurion Expands Clinical Research Capabilities with Strategic Partnership

Clinical Research Partnership Oxurion Biometrics Technology-enabled
PRESS RELEASE

published on 07/21/2026 at 08:00, 2 months 4 days ago

Oxurion élargit sa plateforme de recherche clinique grâce à un partenariat stratégique en biométrie entre Axiodis CRO et KYomed INNOV
Oxurion NV annonce un partenariat avec KYomed INNOV & CEISO pour offrir des services spécialisés de biométrie soutenant le développement clinique. Le partenariat renforce la plateforme technologique de recherche clinique d'Oxurion

Partenariat Stratégique Recherche Clinique Oxurion NV Biométrie KYomed INNOV
PRESS RELEASE

published on 07/21/2026 at 08:00, 2 months 4 days ago

Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV
Oxurion NV announces strategic partnership with KYomed INNOV & CEISO for specialist biometrics services in clinical development, aiming to optimize study design and data quality

Clinical Development Oxurion NV Biometrics Services Specialist Partnership KYomed INNOV & CEISO
BRIEF

published on 07/14/2026 at 18:05, 2 months 11 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Transparency Notification Shareholding Atlas Special Opportunities Oxurion Belgian Legislation
BRIEF

published on 07/14/2026 at 18:05, 2 months 11 days ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actionnariat Notification De Transparence Oxurion Opportunités Spéciales Atlas Législation Belge

Published on 09/26/2026 at 01:00, 4 hours 31 minutes ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 4 hours 31 minutes ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 7 hours 16 minutes ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 12 hours 1 minute ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 14 hours 31 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

Published on 09/26/2026 at 00:01, 5 hours 30 minutes ago

Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 11 hours 1 minute ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 11 hours 16 minutes ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 11 hours 31 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 12 hours 1 minute ago

GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)

View all EQS

Published on 09/25/2026 at 18:00, 11 hours 31 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 11 hours 31 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 11 hours 46 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 11 hours 51 minutes ago

Availability of the 2026 half-year financial report
Published on 09/25/2026 at 17:40, 11 hours 51 minutes ago

Mise à disposition du rapport financier semestriel 2026

View all LES ECHOS COMFI WIRE

News